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ABSTRACT
Oligodendrocyte lineage cells are susceptible to a variety of
insults including hypoxia, excitotoxicity, and reactive oxy-
gen species. Demyelination is a well-recognized feature of
several CNS disorders including multiple sclerosis, white
matter strokes, progressive multifocal leukoencephalopathy,
and disorders due to mitochondrial DNA mutations.
Although mitochondria have been implicated in the demise
of oligodendrocyte lineage cells, the consequences of
mitochondrial respiratory chain defects have not been
examined. We determine the in vitro impact of established
inhibitors of mitochondrial respiratory chain complex IV or
cytochrome c oxidase on oligodendrocyte progenitor cells
(OPCs) and mature oligodendrocytes as well as on differen-
tiation capacity of OPCs from P0 rat. Injury to mature
oligodendrocytes following complex IV inhibition was signif-
icantly greater than to OPCs, judged by cell detachment
and mitochondrial membrane potential (MMP) changes,
although viability of cells that remained attached was not
compromised. Active mitochondria were abundant in pro-
cesses of differentiated oligodendrocytes and MMP was
signiﬁcantly greater in differentiated oligodendrocytes than
OPCs. MMP dissipated following complex IV inhibition
in oligodendrocytes. Furthermore, complex IV inhibition
impaired process formation within oligodendrocyte lineage
cells. Injury to and impaired process formation of oligoden-
drocytes following complex IV inhibition has potentially
important implications for the pathogenesis and repair of
CNS myelin disorders. VC 2010 Wiley-Liss, Inc.
INTRODUCTION
Demyelination is a cardinal neuropathological feature
of several central nervous system (CNS) disorders includ-
ing multiple sclerosis (MS), white matter strokes (WMS),
progressive multifocal leukoencephalopathy (PML),
periventricular leukomalacia (PVL), and certain primary
mitochondrial disorders due to mitochondrial DNA
(mtDNA) mutations (Aboul-Enein et al., 2003; Barnett
and Prineas, 2004; Betts et al., 2004; Gendelman et al.,
1985; Lucchinetti et al., 2000; Tanji et al., 2001). Oligo-
dendrocytes, the myelin forming cells in the CNS, are
derived from oligodendrocyte progenitor cells (OPCs).
OPCs persist in the CNS throughout adulthood and are
responsible for regeneration (remyelination) in demyeli-
nating diseases (ffrench-Constant and Raff, 1986; Frank-
lin and ffrench-Constant, 2008; Levine et al., 2001).
Oligodendrocyte lineage cells are particularly susceptible
to insults such as hypoxia, excitotoxicity, reactive oxygen,
and nitrogen species and cytokines (Cannella and Raine,
2004; Merrill and Scolding, 1999; Smith et al., 1999). The
demise of oligodendrocyte lineage cells following a num-
ber of insults has been shown to involve mitochondria
(Baud et al., 2004a,b; Fragoso et al., 2004; Itoh et al.,
2000; Schoenfeld et al., 2009; Scurlock and Dawson,
1999).
Mitochondria are not only important for ATP produc-
tion but also involved in apoptosis and calcium handling
(Degterev and Yuan, 2008; Taylor et al., 2008). The mito-
chondrial respiratory chain consists of ﬁve complexes
(complex I–complex V) made up of multiple subunits.
Uniquely, mitochondria harbor the only non-nuclear
DNA, mtDNA, which encodes four of the ﬁve complexes
including complex IV. Complex IV or cytochrome c
oxidase (COX), the terminal complex of electron transport
chain, is where over 90% of oxygen is consumed (DiMauro
and Schon, 2003). Complex IV is frequently affected in
primary mitochondrial disorders (Betts et al., 2004; Tanji
et al., 2001). In MS, complex I and complex IV defects
have been reported in chronic white matter and acute
Balo’s type lesions, respectively (Lu et al., 2000; Mahad
et al., 2008). Complex IV defects in acute MS lesions,
based on the loss of the main catalytic subunit (COX-I),
affected oligodendrocytes, astrocytes, and axons (Mahad
et al., 2008). Although well-established complex IV inhibi-
tors, sodium azide and potassium cyanide, have been
used to induce chemical hypoxia in vitro and in vivo the
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consequences of complex IV inhibition in oligodendrocyte
lineage cells have not been determined (Bennett et al.,
1996; Keilin and Hartree, 1945; Marino et al., 2007; Micu
et al., 2006). A recent study identiﬁed differentiating oli-
godendrocytes as more susceptible to inhibition of com-
plex I by rotenone than OPCs (Schoenfeld et al., 2009).
Furthermore, complex I inhibition at levels that did not
compromise cell viability blocked OPC differentiation
(Schoenfeld et al., 2009).
In this study, we investigated the impact of complex IV
inhibition on oligodendrocyte lineage cells from P0 rat
and on the capacity of OPCs to differentiate, in vitro.
Injury mediated by complex IV inhibitors in mature oligo-
dendrocytes (identiﬁed by MBP expression) was greater
than in OPCs (identiﬁed by PDGFRA or NG2 expression).
Mitochondria were abundant and mitochondrial mem-
brane potential (MMP), an electrochemical gradient
generated and maintained across the inner mitochondrial
membrane by proton pumps including complex IV, was
signiﬁcantly greater in processes of differentiated
oligodendrocytes compared to OPCs. The formation of
oligodendrocyte processes was notably impaired when
complex IV was inhibited throughout or brieﬂy at onset
of OPC differentiation. Thus, mitochondrial respiratory
chain dysfunction both injures mature oligodendrocytes
and impairs differentiation of OPCs from P0 rat. These
affects have potentially important implications for
demyelinating disorders, including PVL and MS.
MATERIALS AND METHODS
Cell Culture
Mixed glial cultures were prepared according to the
method of McCarthy and DeVillis (McCarthy and de Vellis,
1980) with minor modiﬁcations. Brieﬂy, the meninges, mid-
brain and olfactory bulbs were removed, and dissociated
rat neonatal cortices (postnatal Day 0 or P0) cut thoroughly
and incubated at 37C for 1 h in MEM containing 4%
Papain, 1% of 4 mg/mL DNase I Type IV and 1% of 24 mg/
mL L-cystein. Dissociated cells were plated on poly-D-lysine
coated tissue culture ﬂasks and grown at 37C with 7.5%
CO2 for 10 days in DMEM 110% FCS 11%Pen/Strep.
OPCs were derived from mixed glial cultures containing
OPCs and microglia grown on astrocyte monolayer by
shaking the ﬂask ﬁrst for 1 h at 250 rpm and then, after
replacing cell culture medium, overnight for a minimum of
18 h at 450 rpm. Microglia were removed by differential
adhesion method. OPCs were seeded into PDL-coated 8-
well chamber slides at a density of 60,000 cells/mL (15,000
cells per chamber) and maintained in SATO medium. For
the ﬁrst 2 days, 10 ng/mL PDGF and 10 ng/mL FGF were
added for proliferation and afterwards the medium was
replaced by SATO with 0.5% FCS for differentiation.
Cells remained in SATO with 0.5% FCS for the 5-day-
period of differentiation with replacement of 25% of the
medium (100 lL) on the 4th day. Cell viability was deter-
mined using Trypan blue and ethidium homodimer extru-
sion methods as well as TUNEL staining. The sublethal
range of sodium azide and potassium cyanide concentra-
tions (1–100 lM) was determined based on greater than
90% of oligodendrocyte lineage that remained attached in
the chamber slides being viable judged by Trypan blue and
ethidium homodimer extrusion and TUNEL staining.
Cytospins
Cytospins were used to capture the cells that detach
from the chamber slides of control and sodium azide
treated chambers and remain suspended in the super-
natant. The supernatant was transferred from chambers
into cytofunnel with ﬁlter card attached to a cytoslide
and placed into Cytocentrifuge. The density of detached
cells in the supernatant was determined using a hemo-
cytometer prior to centrifuging for 4 min at 1200 rpm.
The slides were dried for 1 h prior to immunocyto-
chemical staining (Table 1). The percentage of cells
expressing caspase 9 and MBP or PDGFRA was used for
quantitation rather than cell density as cytospins cause
cell loss and non-uniform distribution of cells.
Immunocytochemistry
For immunocytochemical labeling of P0 rat oligoden-
drocyte lineage cells (Table 1) in culture, 8 well chamber
slides were ﬁxed in PBS containing 2% paraformaldehyde
for 10 min. The ﬁxed cells were incubated in normal goat
serum to prevent non-speciﬁc binding of antibodies. The
secondary antibodies directly conjugated with ﬂuoro-
chromes (Alexa ﬂuor 488, 568, or 633) were used from
molecular probes. The appropriate controls were per-
formed to exclude cross-reactivity and non-speciﬁc binding.
OPCs were identiﬁed based on expression of PDGFRA and
NG2 whereas mature oligodendrocytes expressed MBP.
Mitochondrial Isolation and Spectrophotometric
Measurement of Complex IV and Citrate
Synthase Activity
Cells were washed brieﬂy with PBS and detached from
Petri dishes using TripLETM Express. SATO with 0.5%
FCS was added to detached oligodendrocyte lineage cells
before centrifuging. The cell pellet was washed twice in
sterile PBS, resuspended in 1 mL medium B containing
250 mM Sucrose, 2 mM HEPES, and 0.1 mM EGTA and
kept on ice. The resuspended cells were transferred into a
Abbreviations
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glass homogenizer tube (2 mL Wheaton-smooth surface)
and gently disrupted with a Teﬂon-coated tissue homoge-
nizer. The homogenate was centrifuged for 10 min at
2200 rpm at 4C. The pellet was resuspended before spec-
trophotometric analysis of complex IV and citrate syn-
thase activity as previously described (Kirby et al., 2007).
Respirometry
For respirometry, differentiated cells with or without
exposure to complex IV inhibitor were washed brieﬂy
with PBS, dissociated from plastic using TripLETM
Express and resuspended in SATO with 0.5% FCS. High-
resolution respirometry was performed at 37C using an
Oroboros Oxygraph-2K (Oroboros Instruments, Inns-
bruck, Austria). Approximately 0.5 3 106 cells were
added to the chamber in 2 mL of respiration buffer
(glucose free DMEM, 10% FCS, 0.11 mg/mL Na pyruvate,
0.9 mg/mL galactose), and routine respiratory oxygen
ﬂux was established over 10 min with automatic deduc-
tion of background ﬂux using the online DatLab software
(Oroboros Instruments, Innsbruck, Austria). Cell counts
were made using a small aliquot of cells at the end of the
experiment, and rates were then normalized to pmol of
oxygen consumed per 106 cells per unit of time.
Measurement of Mitochondrial
Membrane Potential
MMP of P0 rat oligodendrocyte lineage cells was mea-
sured using monomeric JC-1 (5,50,6,60-tetrachloro-1,10,3,
30-tetraethylbenzimidazolyl-carbocyanine iodide), which
aggregates in mitochondria depending on the MMP, at a
concentration of 10 lg/mL for 20 min. The ratio of densi-
tometric values for red (590 nm) and green (510–527 nm)
ﬂuorescence was used as an indicator of MMP as previ-
ously described (Baud et al., 2004b). Differentiated oligo-
dendrocytes (5 days) were compared with OPCs (prolifer-
ated without differentiation for 5 days) as immunolabel-
ing to identity oligodendrocytes interfered with MMP and
its measurement.
Measurement of Mitochondrial
Reactive Oxygen Species
Differentiated oligodendrocytes and proliferated OPCs
from P0 rat (Fig. 1), with or without exposure to complex
IV inhibitors (1 lM, 10 lM, and 100 lM for 15 min, 3 h,
and 36 h), were resuspended using TripLETM Express
(GIBCO). MitoSOX (Molecular Probes) prepared in
DMSO was added to resuspended cells, washed in PBS,
for 10 min at 37C. The cells were washed and analyzed
using a FACScan ﬂow cytometer (Becton Dickinson,
Oxford, UK, equipped with 488 nm Argon laser). Experi-
ments were performed on three independent occasions
with measurements based on 10,000 events.
Assessment of Cell Viability and Morphology
To assess cell viability we identiﬁed cells that failed to
extrude Trypan blue and ethidium homodimer. After
removing media and washing with PBS, the cells were
incubated for 5 min in 50% Trypan blue or ethidium
homodimer followed by brief wash with PBS. All cells
that were stained blue or contained red ﬂuorescence were
counted in 20 adjacent 340 ﬁelds of view per chamber.
The assessment of TUNEL positive cells was performed
using In Situ Cell Death Detection Kit, TMR red (Roche
Diagnostics) following brief ﬁxation in 4% paraformalde-
hyde in PBS pH 7.4 and immunocytochemical labeling of
oligodendrocyte lineage cells. Following immunocyto-
chemistry, the cells on slides were washed three times for
5 min in PBS and incubated in permeabilization solution
[freshly prepared 0.1% sodium citrate (BDH) and 0.1%
Triton X-100 (Sigma)] for 3 min on ice. Following three
washing steps, the TUNEL reaction mixture with enzyme
and label solutions was applied to the slides according to
manufacturer’s instructions. Nuclear staining was per-
formed using DAPI. Three independent experiments,
each in triplicate chambers, were performed for controls
and different concentrations of complex IV inhibitors.
Following differentiation of OPCs the morphology of
mature oligodendrocytes expressing MBP were graded.
Cells without processes (category I), with primary or sim-
ple processes (category II), with secondary or complex
processes (category III) and with myelin membranes
based on the presence of continuous myelin staining
between processes (category IV) were identiﬁed.
Microscopy and Quantitation
Immunocytochemical and immunohistochemical stains
were analyzed using Zeiss Axiovert and Zeiss Axioplan
microscopes (Germany), respectively. For ICC (attached
cells in slides and detached cells in cytospins), 10 ﬁelds
(320) were randomly chosen per slide or cytospin and
FITC, Rhodamine and DAPI channels were imaged using
TABLE 1. Details of Antibodies Used for Immunohistochemistry and Immunocytochemistry
Antigen Target Antibody Source
Olig2 Transcription factor Olig2 Rabbit IgG Chemicon
MBP (SMI-94R) Myelin basic protein Mouse IgG1 Covance
PDGFRA Platelet-derived growth factor receptor alpha Mouse IgG1 R&D Systems
NG2 NG2 chondroitin sulfate proteoglycan Rabbit IgG Chemicon
Caspase 9 Cleaved caspase 9 (asp353) Rabbit IgG Cell Signaling Technology
AIF Apoptosis inducing factor Rabbit IgG Cell Signaling Technology
GFAP Glial Fibrillary Acidic Protein Rabbit IgG DAKO
ED1 Macrosialin Mouse IgG1 AbD Serotec
Ox42 CD11b/c Mouse IgG2a Abcam
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an Axiocam mRM (Zeiss). The cells of interest were
manually counted per ﬁeld (10 ﬁelds per chamber in trip-
licates) and an average obtained per chamber or cytospin
for each experiment.
Statistics
Signiﬁcant differences between multiple groups were
analyzed using one-way ANOVA and differences between
two groups was determined using Student’s t test.
RESULTS
Mature Oligodendrocytes More Susceptible to
Injury than Oligodendrocyte Progenitor Cells
Following Complex IV Inhibition
The exposure of oligodendrocyte lineage cells from P0
rat to 1 lM, 10 lM, and 100 lM of sodium azide for 3 h
decreased complex IV activity of mitochondria isolated
from oligodendrocytes by 38.6% (mild), 68.7% (moderate),
and 83.9% (severe), respectively, compared with control
samples when normalized using citrate synthase. In dif-
ferentiated cultures, 93.7% of DAPI positive nuclei, on
average, expressed Olig2 and oligodendrocyte lineage
cells were then characterized based on MBP or PDGFRA
and NG2 labeling (Fig. 2a–f). Less than 5% of cells were
astrocytes based on expression of GFAP and microglia
were not detected in differentiated cultures using ED1
and Ox42 staining.
Complex IV inhibition led to a striking loss of processes
in P0 rat oligodendrocyte lineage cells (Fig. 2a–f). The
extent of injury to oligodendrocytes was reﬂected by a
decrease in the absolute number of cells following inhibi-
tion of complex IV (Fig. 2g). The cell loss was conﬁrmed
by the reduction of DAPI nuclei. Nearly all the cell loss
following complex IV inhibition was due to detachment of
mature MBP1 oligodendrocytes (Fig. 2h). Mature oligo-
dendrocytes remaining on the slides decreased signiﬁ-
cantly in a dose dependent manner when exposed to
complex IV inhibitor whereas (Fig. 2i,j) the number of
OPCs identiﬁed by PDGFRA or NG2 was unchanged,
except with the highest concentration of the inhibitor at
24 h where both OPC and oligodendrocyte numbers were
reduced (Fig. 2g–j). To our surprise 92.8% of all cells that
remained attached to chamber slides extruded Trypan
blue or ethidium homodimer and 86.3 and 93.7% of cells
on the chamber slides did not contain a TUNEL positive
Fig. 1. Experimental timeline. To investigate injury to and detach-
ment of cells following complex IV inhibition, P0 rat OPCs were prolif-
erated for 2 days with PDGF and FGF and then differentiated for 5
days prior to exposure to sodium azide (1, 10, and 100 lM) or potas-
sium cyanide (10 lM and 100 lM). The differentiation capacity of OPCs
was assessed by either persistent or brief exposure to complex IV inhib-
itor at concentrations that did not reduce the number of OPCs (up to
10 lM). In persistent exposure experiments, complex IV inhibitor was
added at the onset of OPC differentiation and kept throughout differen-
tiation (persistent exposure) in the media, 25% of which was replaced
on Day 4. To rule out the possibility that oligodendrocytes differentiate
and then lost rather than fail to differentiate in persistent exposure
experiments, OPCs were brieﬂy exposed to sodium azide for 10 min
and then washed prior to differentiation (brief exposure). The control
samples, appropriate for the time points analyzed, were not exposed
to the inhibitor. I: complex IV inhibitor (sodium azide or potassium
cyanide).
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Fig. 2. Injury to oligodendrocyte lineage
cells from P0 rat following complex IV inhibi-
tion. A, C, and E: There were mature oligo-
dendrocytes expressing MBP (a) and OPCs
expressing PDGFRA (c) or NG2 (e) in oligoden-
drocyte cultures, derived from puriﬁed OPCs
proliferated for 2 days and differentiated for
5 days. B, D, and F: Injury to processes of oli-
godendrocyte lineage cells and loss of mature
oligodendrocytes (b) were the most striking
changes observed following inhibition of com-
plex IV. Images show changes following 100 lM
of sodium azide for 3 h (b and d) and 100 lM of
potassium cyanide for 3 h. TUNEL positive
nuclei (e and f, arrowheads) were detected on
average in 13.7% of oligodendrocyte lineage
cells, which did not change signiﬁcantly follow-
ing complex IV inhibition. G–J: The quantita-
tion of oligodendrocyte lineage cells remaining
attached in the chamber slides showed a concen-
tration dependent reduction in absolute number
of Olig21 nuclei (g). Loss of Olig21 cells was
conﬁrmed by DAPI staining. Mature oligoden-
drocytes were injured and detached following
complex IV inhibition in a dose dependent man-
ner (h). In contrast, OPCs (PDGFRA1 or NG21)
remained attached to the chamber slides and the
numbers were not effected by complex IV inhibi-
tion, except with 100 lM sodium azide at 24 h
(i and j). The experiments, controls, and different
concentrations of inhibitors in triplicate cham-
bers, were performed on 10 separate occasions
from six different litters. *P < 0.001. #P < 0.01.
[Color ﬁgure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]
1831OLIGODENDROCYTES AND MITOCHONDRIA
GLIA
or fragmented nucleus, following severe complex IV inhi-
bition. Potassium cyanide also caused a similar degree
of complex IV inhibition (Cooper and Brown, 2008) and
preferential loss of MBP expressing cells compared with
OPCs (Supp. Info. Fig. 1).
Oligodendrocytes Detach, Express Caspase 9,
and Translocate Apoptosis Inducible Factor to
Nucleus Following Complex IV Inhibition
To conﬁrm that the cell loss following mitochondrial inhi-
bition occurred prior to immunostaining we determined the
cell density in supernatant following complex IV inhibition,
which reﬂected oligodendrocyte lineage cell loss (Fig. 3a).
The detached cells in cytospins expressed caspase 9
and there was evidence of nuclear translocation of AIF
(Fig. 3b,c). The percentage of detached MBP1 cells express-
ing caspase 9 varied depending on the concentration of and
duration of exposure to the inhibitor (Fig. 3d). Caspase 9
expression in detached cells was greater than in cells that
remained attached to slides in controls and chambers with
inhibitor (<8%). In detached OPCs (PDGFRA1 cells), cas-
pase 9 and AIF expression did not change signiﬁcantly fol-
lowing exposure to complex IV inhibitor with on average
8.6% of PDGFRA1 cells expressing caspase 9 and 48.5%
showing nuclear translocation of AIF.
Mitochondrial Membrane Potential Following
Inhibition of Complex IV
Given the differential susceptibility of oligodendrocyte
lineage cells from P0 rat to mitochondrial inhibitors,
we determined the impact of complex IV inhibition on
MMP (Fig. 4). Active mitochondria were abundant in
the processes of differentiated oligodendrocytes whereas
mitochondria were relatively sparse in processes of OPCs
(Fig. 4a,d). The difference in the distribution of mitochon-
dria between oligodendrocyte and OPC processes was
conﬁrmed using MitoTraker green (Fig. 4c,f). The expo-
sure to complex IV inhibitor (100 lM of sodium azide for
15 min) led to a striking dissipation of MMP in both
differentiated oligodendrocytes and OPCs (Fig. 4b,e).
As expected, the uncoupler, carbonylcyanide-p-triﬂuoro-
methoxyphenylhydrazone (FCCP), caused a dramatic
reduction in MMP within differentiated oligodendrocytes
and OPCs (Fig. 4h,i).
Fig. 3. Detached oligodendrocytes in supernatant reﬂect cell loss
following complex IV inhibition and express caspase 9 and translocate
AIF to nucleus. A: The density of oligodendrocyte lineage cells in the
supernatant, later captured on cytospins, increases in a dose dependent
manner following exposure to sodium azide, reﬂecting the extent of cell
loss in chamber slides (Fig. 2e). A density of 10 cells per lL in 400 lL
of supernatant from one chamber represents detachment of 32% of
cells. B and C: Detached MBP expressing cells captured on cytospins
express caspase 9 (b) and show evidence of nuclear translocation of AIF
(c, arrowheads). AIF positive cells without MBP expression (arrow) are
most likely detached OPCs. Co-staining of caspase 9 and AIF was not
possible as both primary antibodies were raised in rabbit. D: The
extent of caspase 9 expression in detached cells varies in a dose and
time dependent manner, with the majority of MBP expressing cells
expressing caspase 9 when exposed to 100 lM of sodium azide. Caspase
9 was not detected in approximately half of the detached MBP express-
ing cells in control chambers or following exposure to 1 lM of sodium
azide. The experiments, controls, and different concentrations of inhibi-
tors in triplicates, were performed on four occasions from different
litters. *P < 0.001. #P < 0.01. [Color ﬁgure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
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Quantitation of MMP, based on the ratio between red
and green ﬂuorescence intensity of JC-1, showed the
mitochondria in processes of differentiated oligodendro-
cytes with complex branch structure to be signiﬁcantly
more active than in processes of OPCs in control
chambers (Fig. 4j). MMP in branches of differentiated
Fig. 4. Mitochondrial membrane potential in live oligodendrocyte lin-
eage cells from P0 rat. A–I: Mitochondrial membrane potential (MMP)
was determined using JC-1. Oligodendrocyte processes in cultures differ-
entiated for 5 days (a) contained strikingly more active mitochondria
(red) than processes of OPCs proliferated without differentiation for 5
days (d). Exposure of differentiated oligodendrocytes and OPCs to com-
plex IV inhibitor (shown following 10 lM of sodium azide exposure for 15
min) led to a notable dissipation of MMP (b and e). Non-aggregated JC-1
is shown by green ﬂuorescence (a–b and d–e). The abundance of mito-
chondria, judged by JC-1 aggregation, in the processes of differentiated
oligodendrocytes (c) relative to undifferentiated OPCs (f) was conﬁrmed
using MitoTraker green. The tips of differentiating oligodendrocytes,
with bulbous morphology on brightﬁeld image (g), were particularly nota-
ble for the presence of mitochondria (g, arrowheads). The mitochondrial
membrane uncoupler, carbonylcyanide-p-triﬂuoromethoxyphenylhydra-
zone (FCCP), dissipated MMP in differentiated oligodendrocytes (h), and
OPCs (i) as expected. J: Quantitation of MMP based on ratio of red to
green ﬂuorescence intensity showed the MMP to be much greater in dif-
ferentiated oligodendrocytes compared with OPCs in controls. MMP
decreased signiﬁcantly in differentiated oligodendrocytes when exposed
to 1 lM of sodium azide for 15 min whereas MMP in OPCs was less sus-
ceptible to low doses (1 lM and 10 lM) of complex IV inhibitor. *P 5
0.001. **P < 0.001. #P 5 0.023. [Color ﬁgure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
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oligodendrocytes with complex structure decreased signif-
icantly following exposure to 1 lM of complex IV inhibitor
whereas 100 lM was required for a signiﬁcant decrease
in MMP within OPCs. Complex IV inhibitor (100 lM)
dissipated MMP to similar extent to FCCP in oligoden-
drocyte lineage cells. The extent of MMP reduction as a
percentage of baseline was greater in differentiated oligo-
dendrocytes (71.3%) than OPCs (48.3%).
Mitochondrial Superoxide Production Following
Inhibition of Complex IV
Given the potential role of reactive oxygen species
(ROS) in the vulnerability of oligodendrocyte lineage cells
to a number of insults (see Supp. Info. Table 1), we meas-
ured mitochondrial superoxide in differentiated and then
resuspended live oligodendrocytes as well as undifferenti-
ated OPCs. Interestingly, superoxide levels in differenti-
ated oligodendrocytes and OPCs exposed to sodium azide,
at variable concentrations (1, 10, and 100 lM) and expo-
sure times (15 min, 3 h, and 36 h), did not change com-
pared with cells not exposed to inhibitors (Supp. Info.
Fig. 2).
Complex IV and Oligodendrocyte
Progenitor Cell Proliferation
As OPCs from P0 rat withstand complex IV dysfunction
better than their mature counterparts we investigated
whether complex IV inhibition affected OPC prolifera-
tion. Interestingly, the exposure of OPCs to sodium azide
did not affect PDGF and FGF mediated OPC proliferation
over a 48 h period, judged by the absolute number of
Olig2 expressing cells (Supp. Info. Table 2).
Complex IV and Oligodendrocyte
Progenitor Cell Differentiation
As the next step we determine the impact of mitochon-
drial injury on differentiation capacity of P0 rat OPCs
using complex IV inhibitors at concentrations (up to
10 lM of inhibitor) that did not reduce OPC density
(Fig. 1). The complex IV activity of mitochondria isolated
from differentiated oligodendrocyte lineage cells persis-
tently exposed to 1 lM and 10 lM of sodium azide for the
5 days decreased by 35.3% (mild) and 65.7% (moderate),
respectively, compared with control samples when
normalized using citrate synthase. The oxygen consump-
tion of oligodendrocyte lineage cells was 80.1% and 66.1%
following persistent inhibition with 1 lM and 10 lM of
sodium azide, respectively, compared with controls. The
number of OPCs in culture following persistent exposure
to complex IV inhibitor was not signiﬁcantly different
compared with controls (Fig. 5a). There was a modest
decrease in number of MBP1 cells with exposure to 10
lM of sodium azide (Fig. 5b). The morphological differ-
ence in oligodendrocytes differentiated with complex IV
inhibitors was striking (Fig. 5c). Intense MBP immuno-
ﬂuorescence was noted in a number of oligodendrocytes
without processes when complex IV was inhibited
(Fig. 5g). The majority of (>90%) MBP1 cells extruded
Trypan blue and did not express caspase 9 or show nu-
clear translocation of AIF (not shown). The ﬁndings on
the percentage and morphology of MBP1 cells and OPC
survival were conﬁrmed using potassium cyanide (Supp.
Info. Fig. 3).
To establish whether the reduction in percentage of
MBP expressing cells that differentiated following con-
stant exposure to a complex IV inhibitor was due to a
reduction in the capacity to differentiate or differen-
tiation into a more susceptible phenotype, we brieﬂy
exposed OPCs in suspension to inhibitors, prior to differ-
entiation (Fig. 1). Inhibition of complex IV following brief
exposure of cells to sodium azide, which is a reversible
inhibitor of complex IV (Bennett et al., 1996; Berndt
et al., 2001), was transient as indicated by spectrophoto-
metric measurement of complex IV activity. The number
of mature oligodendrocytes did not signiﬁcantly change
following transient complex IV inhibition (Fig. 5d,e).
However, the morphological changes following brief
exposure to complex IV inhibitor were as striking as the
ﬁndings following persistent exposure (Fig. 5f).
DISCUSSION
In this study, we identiﬁed mature oligodendrocytes
differentiated from P0 rat as more prone to mitochondrial
respiratory chain complex IV inhibitor mediated injury
than OPCs. Furthermore, complex IV inhibition through-
out and brieﬂy prior to differentiation of OPCs impaired
formation of oligodendrocyte processes.
Surprisingly inhibitors of mitochondrial respiratory
chain complex IV did not signiﬁcantly change the viabil-
Fig. 5. Density and morphology of mature oligodendrocytes when
P0 rat OPCs were persistently or brieﬂy exposed to complex IV inhibi-
tor during or prior to differentiation. A–C: When proliferated OPCs
were persistently exposed to sodium azide throughout the 5-day-period
of differentiation (Fig. 1) at concentrations that did not effect the viabil-
ity (up to 10 lM of sodium azide), the total number of oligodendrocyte
lineage cells (MBP1, PDGFRA1, or NG21) remaining in the chamber
slides is similar compared with controls (a). With 10 lM of sodium
azide there was a signiﬁcant reduction in the percentage of MBP1 cells
reﬂecting either impaired differentiation or injury to differentiated
MBP1 cells (b). When mature oligodendrocytes were categorized into
rounded (category I, GI), simple processes (category II, GII), complex
processes (category III, GIII), or with MBP1 membrane (category IV,
GIV) the proportion of MBP1 cells lacking processes or with simple
processes was signiﬁcantly greater when differentiated in the presence
of complex IV inhibitor compared with controls (c). D–F: Brief exposure
of OPCs to variable concentrations of sodium azide prior to differen-
tiation (Fig. 1) led to similar number of oligodendrocyte lineage cells
compared with controls (d). We did not detect a signiﬁcant change in
the number of MBP1 cells in brief exposure experiments (e). There
was a signiﬁcant increase in MBP expressing cells without processes or
with simple processes in brief exposure experiments (f). The experi-
ments, controls, and different concentrations of inhibitors in triplicate
chambers, were performed on eight occasions from different litters.
*P < 0.01. **P < 0.001. [Color ﬁgure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]
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ity of cells that remained attached. Instead cells, mostly
mature oligodendrocytes, detached from the slides follow-
ing inhibition of complex IV in a concentration dependent
manner. Energy requirements of mature oligodendrocyte
processes appear to be much greater than processes of
OPC. MMP in attached mature oligodendrocyte processes
decreased signiﬁcantly at lower levels of complex IV inhi-
bition and to a greater extent as a proportion of controls
than MMP in OPC processes. Furthermore, injury to
processes as a prerequisite to cell detachment is sug-
gested by the differentiation experiments with persistent
inhibitors where process formation was impaired and cell
detachment was modest. Imbalance of calcium down-
stream of mitochondrial injury may be important in the
differential susceptibility of oligodendrocytes to complex
IV inhibition (Marino et al., 2007; Micu et al., 2006).
Maturation dependent susceptibility of oligodendrocyte
lineage cells has been the focus of a number of studies.
Several studies have reported OPCs to be more vulnera-
ble than MBP1 oligodendrocytes. Although mitochondria
have been implicated in oligodendrocyte death in a num-
ber of studies complex IV activity was not determined in
previous studies and mitochondrial activity and cell
viability were assessed using MTT assay, which is based
mitochondrial dehydrogenases. Superoxide, implicated in
a number of previous studies, was not involved in the
differential susceptibility in this study, which is not un-
expected as MMP dissipation may prevent ROS upregula-
tion and, unlike complex I, complex IV defects need to be
severe to upregulate ROS (Adam-Vizi, 2005; Huttemann
et al., 2008). A limitation of most cell culture studies is
that only adherent cells are usually analyzed. We cap-
tured the detached cells following complex IV inhibition
and detected expression of caspase 9 and nuclear trans-
location of AIF in majority of MBP1 cells (Garrido et al.,
2006; Goldstein et al., 2000; Susin et al., 1999). Given the
sparse expression of cell death markers in attached cells
exposed to inhibitors, cell detachment per se may have
triggered cell death. Investigation of differential suscepti-
bility of oligodendrocytes to complex IV inhibitors in vivo,
will address some of the limitations of in vitro studies.
Furthermore, as the outcome of in vitro studies is inﬂu-
enced by differences in experimental paradigm, age of
animals, species from which OPCs were derived and
culture techniques our ﬁndings may not be applicable to
oligodendrocytes differentiated in vivo and neonatal OPC
from other species.
The most notable feature to be affected by complex IV
inhibition during OPC differentiation was formation and
structure of oligodendrocyte processes. Differentiation of
OPCs into myelinating oligodendrocytes is a meta-
bolically active process (Bauer et al., 2009; Cowell et al.,
2008; Kirby et al., 2006; Kirischuk et al., 1995; Schoen-
feld et al., 2009). Mitochondria provide acetyl-CoA, neces-
sary for cholesterol synthesis and myelination (Schoen-
feld et al., 2009). Mitochondrial location and activity
appear to be important for calcium signaling (Haak et al.,
2000; Simpson and Russell, 1996). The abundance of
active mitochondria in the tip of oligodendrocyte pro-
cesses and morphological differences following complex
IV inhibition suggest an important role for mitochondria
in process formation (Kirischuk et al., 1995). Oligoden-
drocyte lineage cells (O41) lacked processes in a subset of
PVL cases (Billiards et al., 2008; Segovia et al., 2008). A
block in OPC differentiation has also been reported in
MS (Chang et al., 2000, 2002; Kuhlmann et al., 2008;
Wolswijk, 1998). ROS damage mtDNA within oligoden-
drocytes and enhancing DNA repair rescues oligodendro-
cytes, in vitro (Druzhyna et al., 2005). Further studies
are needed to explore mitochondria and mitochondrial
DNA within oligodendrocyte lineage cells in PVL and
chronic MS lesions as well as determine whether remyeli-
nation is present in primary mtDNA disorders.
Mitochondrial dysfunction is now established in WMS
and MS. Our in vitro ﬁndings recapitulate some of the
features of WMS, PVL, and MS: distal oligodendroglio-
pathy involving ﬁrst the processes and then leading to
oligodendrocyte loss, partial preservation of OPCs, and
differentiation block with limited remyelination. We
propose complex IV defects as an important cause of
oligodendrocyte injury and differentiation block of OPCs
in demyelinating disorders.
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